"10.1371_journal.pone.0112672","plos one","2014-11-10T00:00:00Z","Jason K F Wong; Anthony D Metcalfe; Richard Wong; Jim Bush; Chris Platt; Arnaud Garcon; Nick Goldspink; Duncan A McGrouther; Mark W J Ferguson","Plastic Surgery Research, Faculty of Medicine and Human Sciences, University of Manchester, Manchester, United Kingdom; Renovo Ltd, Core Technology Facility, Manchester, United Kingdom","Conceived and designed the experiments: JW DAM MWJF. Performed the experiments: JW ADM JB CP AG NG RW. Analyzed the data: JW ADM JB CP NG RW. Contributed reagents/materials/analysis tools: JW DAM MWJF. Wrote the paper: JW ADM DAM MWJF. Developed the in vivo model and performed all mouse in vivo experimentation pertaining to the study: JW. Designed and developed all the ex vivo and in vitro experimentation pertaining to the study: ADM. Performed the live dead assay and p38 immunoblot analysis: RW. Contributed to the design of the rabbit in vivo experimentations: JB. Performed the ex vivo and in vitro migration assays: CP. Performed the proliferation assays: AG. Analysed and quantified the ex vivo and in vitro assays: NG.","Anthony Metcalfe, Jim Bush, Chris Platt, Arnaud Garcon, and Nick Goldspink were all past employees of Renovo Plc at time of manuscript preparation. Professor Mark Ferguson is co-founder and previous CEO and CSO of Renovo Plc. All Renovo staff had shares or share options. There is a patent on “Inhibition of tendon Adhesions” (WO2011033306 A1), and product has been developed and trialed for clinical use. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2014","11","Jason K F Wong","JKFW",9,TRUE,3,7,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
